Author

Sarah C Mott

Observed name: Sarah Mott

Institution: University of Iowa Holden Comprehensive Cancer Center

Observed institution: University of Iowa Holden Comprehensive Cancer Center

OpenAlex ID: A5048783256

A phase I study of vemurafenib and decitabine in metastatic melanoma.

2015 · Sneha Deepak Phadke, Eric Steven Engelman, et al. · Journal of Clinical Oncology · 2

Discrepancy between treatment goals documentation by oncologists and their understanding among cancer patients.

2015 · Varun Monga, Hassan Kaleem, et al. · Journal of Clinical Oncology · 1

Utility of CD3+ T- lymphocyte chimerism following myeloablative allogeneic hematopoietic stem cell transplant (HSCT): A single center experience.

2015 · Andrea O. Akpoguma, Lindsay Dozeman, et al. · Journal of Clinical Oncology · 1

Impact of Absolute Lymphocyte Count at Time of Antithymocyte Globulin on Outcomes of Allogeneic Unrelated Hematopoietic Cell Transplantation with Busulfan and Fludarabine Myeloablative Conditioning

2019 · Adithya Chennamadhavuni, Kalyan Nadiminti, et al. · Blood

AML relapse following allogeneic hematopoietic stem cell transplant: a single center experience.

2015 · Andrea O. Akpoguma, Connie Grobe, et al. · Journal of Clinical Oncology

A novel immunohistochemistry (IHC) algorithm for assigning cell of origin status in diffuse large B-cell lymphoma (DLBCL) that better predicts survival as compared to the Hans algorithm.

2014 · Kalyan Nadiminti, Michel Nasr, et al. · Journal of Clinical Oncology

Works count: 6

Citation count: 4

H-index: 1

I10-index: